UBS Group »

Agex Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Agex Therapeutics shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Agex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Agex Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agex Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $237 618 0.39
2023-09-30 $161 235 0.69
2023-06-30 $5.0k 5.7k 0.89
2023-03-31 $22 35 0.66
2022-12-31 $7.3k 14k 0.54
2022-09-30 $0 35 0.00
2022-06-30 $0 35 0.00
2022-03-31 $0 35 0.00
2021-12-31 $0 16k 0.00
2021-09-30 $0 75 0.00
2021-06-30 $0 35 0.00
2021-03-31 $3.9k 2.0k 1.93
2020-12-31 $10k 6.8k 1.47
2020-09-30 $21k 21k 0.98
2020-06-30 $7.3k 7.4k 0.98
2020-03-31 $13k 14k 0.89
2019-12-31 $63k 32k 1.97
2019-09-30 $39k 20k 1.98
2019-06-30 $34k 8.9k 3.79
2019-03-31 $12k 3.5k 3.42
2018-12-31 $0 4.2k 0.00